Ixekizumab-induced urticaria is associated with the short duration of remission in psoriasis by activation of mast cells- Supplemental Data

Published: 15 January 2024| Version 1 | DOI: 10.17632/hdhg8byr9b.1
Contributors:
Li Zhang,
,
,
,
,
,
,
,
,
,
,

Description

"Ixekizumab-induced urticaria is associated with the short duration of remission in psoriasis by activation of mast cells" Supplemental Data for JAAD Article

Files

Categories

Dermatology, Mast Cell, Psoriasis

Licence